According to a meta-analysis evaluating 453 trials and 21 antidiabetic treatments, oral semaglutide reduces all-cause mortality and cardiovascular death, with the lowest odds ratios (ORs) among the treatments evaluated (empagliflozin, liraglutide, extended-release exenatide, dapagliflozin, dulaglutide, lixisenatide, canagliflozin, pioglitazone, DPP-4 inhibitors, subcutaneous semaglutide, sulphonylureas) [56]
Take small sips of water as you snack, and avoid anything too sweet, greasy, or heavily spiced.
[DOI] [PubMed] [Google Scholar] 9.Yoon KA, et al
With Mounjaro, many people experience effective weight loss at lower doses
This story was reported from Los Angeles.
[DOI] [PubMed] [Google Scholar] Kim J., et al